Potential benefit of final kissing balloon inflation after single stenting for the treatment of bifurcation lesions - Insights from optical coherence tomography Observations-

Circulation Journal

Volumn 77, Issue 5, 2013, Pages 1193-1201

  Hariki, Hirotoshi ^a   Shinke, Toshiro ^a   Otake, Hiromasa ^a   Shite, Junya ^a   Nakagawa, Masayuki ^a   Inoue, Takumi ^a   Osue, Tsuyoshi ^a   Iwasaki, Masamichi ^a   Taniguchi, Yu ^a   Nishio, Ryo ^a   Hiranuma, Noritoshi ^a   Kinutani, Hiroto ^a   Konishi, Akihide ^a   Hirata, Ken Ichi ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Coronary artery disease; Drug eluting stent; Optical coherence tomography; Thrombus

Indexed keywords

AGED; ARTICLE; CONTROLLED STUDY; CORONARY BIFURCATION LESION; DRUG ELUTING STENT; FEMALE; FINAL KISSING INFLATION; FISHER EXACT TEST; FOLLOW UP; HEART DISEASE; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; OPTICAL COHERENCE TOMOGRAPHY; REVASCULARIZATION; STENT; THROMBUS;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON, CORONARY; CORONARY ARTERY DISEASE; CORONARY THROMBOSIS; CORONARY VESSELS; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSTHESIS DESIGN; RETROSPECTIVE STUDIES; TIME FACTORS; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME;

EID: 84876766329     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-12-0848     Document Type: Article

References (27)

1. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346: 1773-1780.
2. Thuesen L, Kelbaek H, Klovgaard L, Helqvist S, Jorgensen E, Aljabbari S, et al. Comparison of sirolimus-eluting and bare metal stents in coronary bifurcation lesions: Subgroup analysis of the Stenting Coronary Arteries in Non-Stress/Benestent Disease Trial (SCANDSTENT). Am Heart J 2006; 152: 1140-1145.
3. Applegate R, Hermiller J, Williams J, Gordon P, Doostzadeh J, Cao S, et al. Evaluation of the effects of everolimus-eluting and paclitaxeleluting stents on target lesions with jailed side branches: 2-year results from the SPIRIT III randomized trial. Catheter Cardiovasc Interv 2010; 76: 644-651.
4. Steigen TK, Maeng M, Wiseth R, Erglis A, Kumsars I, Narbute I, et al. Randomized study on simple versus complex stenting of coronary artery bifurcation lesions: The Nordic Bifurcation Study. Circulation 2006; 114: 1955-1961.
5. Hildick-Smith D, de Belder AJ, Cooter N, Curzen NP, Clayton TC, Oldroyd KG, et al. Randomized trial of simple versus complex drugeluting stenting for bifurcation lesions: The British bifurcation coronary study: Old, new, and evolving strategies. Circulation 2010; 121: 1235-1243.
6. Niemela M, Kervinen K, Erglis A, Holm NR, Maeng M, Christiansen EH, et al. Randomized comparison of final kissing balloon dilatation versus no final kissing balloon dilatation in patients with coronary bifurcation lesions treated with main vessel stenting: The NordicBaltic Bifurcation Study III. Circulation 2011; 123: 79-86.
7. Murasato Y, Hikichi Y, Horiuchi M. Examination of stent deformation and gap formation after complex stenting of left main coronary artery bifurcations using microfocus computed tomography. J Interv Cardiol 2009; 22: 135-144.
8. Otake H, Shite J, Ako J, Shinke T, Tanino Y, Ogasawara D, et al. Local determinants of thrombus formation following sirolimus-eluting stent implantation assessed by optical coherence tomography. JACC Cardiovasc Interv 2009; 2: 459-466.
9. Kyono H, Guagliumi G, Sirbu V, Rosenthal N, Tahara S, Musumeci G, et al. Optical coherence tomography (OCT) strut-level analysis of drug-eluting stents (DES) in human coronary bifurcations. EuroIntervention 2010; 6: 69-77.
10. Matsumoto D, Shite J, Shinke T, Otake H, Tanino Y, Ogasawara D, et al. Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: Evaluated by optical coherence tomography. Eur Heart J 2007; 28: 961-967.
11. Medina A, Suarez de Lezo J, Pan M. A new classification of coronary bifurcation lesions. Rev Esp Cardiol 2006; 59: 183 (in Spanish).
12. Morino Y, Yamamoto H, Mitsudo K, Nagaoka M, Takeuchi H, Okamoto N, et al. Functional formula to determine adequate balloon diameter of simultaneous kissing balloon technique for treatment of bifurcated coronary lesions: Clinical validation by volumetric intravascular ultrasound analysis. Circ J 2008; 72: 886-892.
13. Dzavik V, Kharbanda R, Ivanov J, Ing DJ, Bui S, Mackie K, et al. Predictors of long-term outcome after crush stenting of coronary bifurcation lesions: Importance of the bifurcation angle. Am Heart J 2006; 152: 762-769.
14. Koo BK, Park KW, Kang HJ, Cho YS, Chung WY, Youn TJ, et al. Physiological evaluation of the provisional side-branch intervention strategy for bifurcation lesions using fractional flow reserve. Eur Heart J 2008; 29: 726-732.
15. Murasato Y, Horiuchi M, Otsuji Y. Three-dimensional modeling of double-stent techniques at the left main coronary artery bifurcation using micro-focus X-ray computed tomography. Catheter Cardiovasc Interv 2007; 70: 211-220.
16. Hikichi Y, Inoue T, Node K. Benefits and limitations of cypher stentbased bifurcation approaches: In vitro evaluation using micro-focus CT scan. J Interv Cardiol 2009; 22: 128-134.
17. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, et al. Pathology of drug-eluting stents in humans: Delayed healing and late thrombotic risk. J Am Coll Cardiol 2006; 48: 193-202.
18. Farb A, Burke AP, Kolodgie FD, Virmani R. Pathological mechanisms of fatal late coronary stent thrombosis in humans. Circulation 2003; 108: 1701-1706.
19. Nakazawa G, Yazdani SK, Finn AV, Vorpahl M, Kolodgie FD, Virmani R. Pathological findings at bifurcation lesions: The impact of flow distribution on atherosclerosis and arterial healing after stent implantation. J Am Coll Cardiol 2010; 55: 1679-1687.
20. Nishio R, Shinke T, Otake H, Sawada T, Haraguchi Y, Shinohara M, et al. Effect of cytochrome P450 2C19 polymorphism on target lesion outcome after drug-eluting stent implantation in Japanese patients receiving clopidogrel. Circ J 2012; 76: 2348-2355.
21. Sawada T, Shinke T, Shite J, Honjo T, Haraguchi Y, Nishio R, et al. Impact of cytochrome P450 2C19*2 polymorphism on intra-stent thrombus after drug-eluting stent implantation in Japanese patients receiving clopidogrel. Circ J 2011; 75: 99-105.
22. Liu Y, Imanishi T, Kubo T, Tanaka A, Kitabata H, Tanimoto T, et al. Assessment by optical coherence tomography of stent struts across side branch: Comparison of bare-metal stents and drug-elution stents. Circ J 2011; 75: 106-112.
23. Kotani J, Awata M, Nanto S, Uematsu M, Oshima F, Minamiguchi H, et al. Incomplete neointimal coverage of sirolimus-eluting stents: Angioscopic findings. J Am Coll Cardiol 2006; 47: 2108-2111.
24. Guerin P, Pilet P, Finet G, Goueffic Y, N'Guyen JM, Crochet D, et al. Drug-eluting stents in bifurcations: Bench study of strut deformation and coating lesions. Circ Cardiovasc Interv 2010; 3: 120-126.
25. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005; 293: 2126-2130.
26. Nasu K, Oikawa Y, Yoshikawa R, Kadotani M, Takeda Y, Ota H, et al; on behalf of SKT investigators. A randomized comparison of sirolimusvs. paclitaxel-eluting stents for treatment of bifurcation lesions by single stent and kissing balloon: Results of the SINGLE KISS trial. Int J Cardiol 2011 November 8, doi:10.1016/j.ijcard.2011. 10.101 [Epub ahead of print].
27. Kawamori H, Shite J, Shinke T, Otake H, Sawada T, Kato H, et al. The ability of optical coherence tomography to monitor percutaneous coronary intervention: Detailed comparison with intravascular ultrasound. J Invasive Cardiol 2010; 22: 541-545.